• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统的患者参与,用于急性白血病和淋巴瘤的家庭门诊复杂化疗管理。

Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.

机构信息

Department of Haematology, University Hospital of Copenhagen Rigshospitalet Denmark, Copenhagen, Denmark.

Department of Clinical Microbiology, University Hospital of Copenhagen Rigshospitalet Denmark, Copenhagen, Denmark.

出版信息

Br J Haematol. 2018 Jun;181(5):637-641. doi: 10.1111/bjh.15249. Epub 2018 Apr 20.

DOI:10.1111/bjh.15249
PMID:29676445
Abstract

Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In-hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in-hospital beds for patients in need of them.

摘要

基于全面患者参与的经验,我们展示了在急性白血病患者和接受(卡莫司汀、依托泊苷、阿糖胞苷、美法仑)BEAM 方案治疗的淋巴瘤患者中,使用便携式可编程输注泵(PPP)进行家庭化疗管理的实施数据。对 84 名接受 177 个 PPP 管理化疗周期的患者的数据进行了分析,结果显示设备出现小故障的情况下,安全性令人信服,且患者满意度高。1197 个治疗日中,有 52%的患者可以减少住院天数。从患者的角度来看,家庭使用 PPP 有几个优势,而且还可以为需要的患者腾出住院床位。

相似文献

1
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.系统的患者参与,用于急性白血病和淋巴瘤的家庭门诊复杂化疗管理。
Br J Haematol. 2018 Jun;181(5):637-641. doi: 10.1111/bjh.15249. Epub 2018 Apr 20.
2
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.高剂量环磷酰胺、表柔比星、长春新碱和泼尼松(CEB)与大剂量化疗联合自体干细胞移植(BEAM)治疗淋巴瘤的比较
Bone Marrow Transplant. 2004 Oct;34(7):581-7. doi: 10.1038/sj.bmt.1704637.
3
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.地塞米松、卡莫司汀、依托泊苷、阿糖胞苷和美法仑(地塞米松-卡莫司汀-依托泊苷-阿糖胞苷-美法仑方案),随后进行大剂量化疗和干细胞救援——这是一种针对难治性或复发性惰性淋巴瘤患者的高效治疗方案。
Leuk Lymphoma. 2000 Mar;37(1-2):115-23. doi: 10.3109/10428190009057634.
4
Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.卡莫司汀、依托泊苷、阿糖胞苷和美法仑(BEAM)-抗人淋巴细胞球蛋白异基因干细胞移植治疗侵袭性非霍奇金淋巴瘤:英国血液与骨髓移植学会的疗效分析
Biol Blood Marrow Transplant. 2015 Mar;21(3):483-8. doi: 10.1016/j.bbmt.2014.11.673. Epub 2014 Dec 6.
5
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.复发滤泡性淋巴瘤患者的门诊自体造血干细胞移植
Ann Hematol. 2006 Oct;85(10):723-9. doi: 10.1007/s00277-006-0149-6. Epub 2006 Jul 11.
6
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.持续输注、患者自控止吐泵用于门诊大剂量化疗给药的安全性和有效性。
Bone Marrow Transplant. 1999 Sep;24(5):561-6. doi: 10.1038/sj.bmt.1701909.
7
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.利妥昔单抗密集化疗联合或不联合大剂量化疗和自体干细胞移植治疗高危弥漫性大 B 细胞淋巴瘤(DLCL04):一项多中心、开放标签、随机、对照、3 期研究的最终结果。
Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.
8
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.100例接受大剂量BEAM化疗及外周血祖细胞移植治疗的非霍奇金淋巴瘤或霍奇金病患者的中性粒细胞减少性感染:门诊治疗是一种可行的选择。
Bone Marrow Transplant. 1999 Mar;23(6):599-605. doi: 10.1038/sj.bmt.1701610.
9
BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.BEAC方案还是BEAM方案用于非霍奇金淋巴瘤患者的大剂量治疗?一项关于毒性和疗效的单中心分析
Leuk Lymphoma. 2003 Jul;44(7):1151-8. doi: 10.1080/1042819031000083028.
10
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.采用卡莫司汀、依托泊苷、阿糖胞苷、美法仑加氨磷汀进行预处理方案用于门诊自体干细胞移植:97例淋巴瘤患者的可行性及结果
Leuk Lymphoma. 2014 Jul;55(7):1657-60. doi: 10.3109/10428194.2013.842989. Epub 2013 Nov 1.

引用本文的文献

1
Transforming acute care: a scoping review on the effectiveness, safety and implementation challenges of Hospital-at-Home models.转变急性护理:关于居家医院模式的有效性、安全性及实施挑战的范围综述
BMJ Open. 2025 Aug 8;15(8):e098411. doi: 10.1136/bmjopen-2024-098411.
2
Hospital at home for oncologic patients: SEOM-SEHAD consensus on clinical practice.肿瘤患者的居家医院:SEOM-SEHAD关于临床实践的共识
Clin Transl Oncol. 2025 Apr 23. doi: 10.1007/s12094-025-03875-4.
3
Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience.
使用连续非卧床给药装置(CADD)进行门诊胃肠外抗菌治疗(OPAT),可进行每日多次给药:挪威经验的简要报告。
JAC Antimicrob Resist. 2024 Oct 14;6(5):dlae155. doi: 10.1093/jacamr/dlae155. eCollection 2024 Oct.
4
Development of an intravenous chemotherapy intervention for children and adolescents with cancer administered by their parents at home (INTACTatHome).开发一种由父母在家为癌症患儿和青少年进行的静脉化疗干预措施(INTACTatHome)。
BMC Health Serv Res. 2023 Jun 20;23(1):664. doi: 10.1186/s12913-023-09613-2.
5
"It's a part of the patient": The experiences of patients with cancer undergoing home-based chemotherapy from patients' and nurses' perspectives.“这是患者的一部分”:从患者和护士的角度看癌症患者居家化疗的经历
Asia Pac J Oncol Nurs. 2022 Apr 22;9(8):100072. doi: 10.1016/j.apjon.2022.04.011. eCollection 2022 Aug.
6
Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial.多发性硬化症患者的家庭纳武单抗输注:一项先导随机交叉试验。
Ann Clin Transl Neurol. 2021 Aug;8(8):1610-1621. doi: 10.1002/acn3.51410. Epub 2021 Jul 21.
7
Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study.患者大使在急性白血病初诊患者治疗中的支持作用:一项可行性研究。
Support Care Cancer. 2021 Jun;29(6):3077-3089. doi: 10.1007/s00520-020-05819-w. Epub 2020 Oct 13.
8
Qualitative factors shaping MS patients' experiences of infusible disease-modifying drugs: a critical incident technique analysis.定性因素塑造多发性硬化症患者对输注型疾病修正药物的体验:关键事件技术分析。
BMJ Open. 2020 Aug 20;10(8):e037701. doi: 10.1136/bmjopen-2020-037701.
9
Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis.为多发性硬化症患者开发那他珠单抗家庭输注护理模式。
J Infus Nurs. 2019 Nov/Dec;42(6):289-296. doi: 10.1097/NAN.0000000000000343.